CITRUCEL SUGAR-FREE OTC
Generic Name and Formulations:
Methylcellulose 2g per 10.2g; pwd; contains phenylalanine; orange flavor.
Indications for CITRUCEL SUGAR-FREE:
Constipation, adjunct in diverticulosis, irritable bowel syndrome.
1 rounded tablespoonful (10.2g) in 8oz of water or juice 1–3 times daily.
<6 yrs: not recommended. ≥6 yrs: ½ adult dose 1–3 times daily.
Signs/symptoms of appendicitis. Intestinal obstruction. Fecal impaction.
Narrowed intestinal lumen. Discontinue if rectal bleeding or if no bowel movement occurs.
Reduced absorption of salicylates, digitalis, oral anticoagulants, nitrofurantoins, others.
Esophageal, gastric, enteral, rectal obstruction.
Pwd—16oz, 24oz, 30oz; Packets (single-dose)—20; Sugar-free pwd—8.6oz, 16.9oz
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- Despite Promising Trial Results, Skeptics Raise Red Flags About Anlotinib's Efficacy in Heavily Treated NSCLC
- Higher Risk of MGUS in Relatives of Patients With Multiple Myeloma Confirmed
- Brentuximab Vedotin Combo Active in Older Patients With Hodgkin Lymphoma
- Prostate Cancer Drug Resistance Mediated by Epigenetic Changes
- Nilotinib and Dasatinib Confer Similar Outcomes for Chronic-Phase CML